SenzaGen appoints Axel Sjöblad as new CEO – mission to lead the company into an expansive sales phase
Over the last few years SenzaGen has made major progress, bringing the company to the next phase with increased focus on marketing and sales. In accordance with the company's strategic plan and accelerating commercial activities, SenzaGen's Board has appointed Axel Sjöblad as new CEO starting June 17, 2019. Axel most recently held the position as CEO of BioGaia and replaces Anki Malmborg Hager, who after five years as CEO, is nominated to become a member of the company’s board.Axel Sjöblad has extensive experience in managing and developing global growth companies in medical technology and